Yamaguchi University · University Hospital

Research keywordsurothelial carcinoma・pembrolizumab response biomarkers・ABO-incompatible kidney transplantation・osteoclast survival signaling・bladder cancer trimodal therapy・oral and gut microbiota

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report2026 · Transplantation Proceedings
• Necrotic-cell-activated macrophages drive an ERK-Bcl-xL survival pathway in osteoclasts and confer bisphosphonate resistance.2026 · Biochemical and biophysical research communications
• Extracellular vesicles-derived LncRNA MAFG-AS1 predicts clinical response to pembrolizumab in patients with advanced urothelial carcinoma2026 · Molecular Biology Reports
• High-Concentration Hydrogen Delivery During Dialysis Using an Innovative Direct Dissolution Technique: In Vivo Kinetics in a Canine Model.2025 · ASAIO journal (American Society for Artificial Internal Organs : 1992)

• Official profile